LesionQuant for assessment of MRI in MS

November 18, 2023
< 1 mins

Category: Published research
Product: NeuroQuant MS
Disease: Multiple sclerosis

LesionQuant for assessment of MRI in MS —a promising supplement to the visual scan inspection

Quantitative measurements of lesion volume, lesion count, distribution of lesions, and brain atrophy have a potentially significant value for evaluating disease progression. We hypothesize that utilizing software designed for evaluating MRI data in MS will provide more accurate and detailed analyses compared to the visual neuro-radiological evaluation. 2020.

[button]Download[/button]

Topic: Published research

More Resources

10/30/2026

What to Expect at the Cortechs.ai Booth at RSNA 2026

Visit Cortechs.ai at RSNA 2026, Booth 5107. See Cortechs Connect, FDA-cleared NeuroQuant PET and live demos of our AI quantitative imaging tools.

Blogs

10/14/2026

Cortechs.ai and CARPL.ai Partner to Expand Global Access to AI-Powered Imaging Solutions

Cortechs.ai joins CARPL.ai’s enterprise AI ecosystem to expand access to quantitative imaging solutions worldwide.

Product updates

10/10/2026

World Mental Health Day: Why Brain Health and Mental Health Belong Together

Behind every brain scan is a person. Here’s why their voice matters.

Blogs

09/30/2026

Today’s Examination Becomes Tomorrow’s Baseline: The Benefits of Performing Quantitative Analysis on Every Brain MRI

A single brain MRI shows where a patient is today. A quantitative baseline can help show how the brain changes over time.

Blogs

09/18/2026

What a Head CT Can and Can’t Tell You About a Concussion

For Concussion Awareness Day, learn how quantitative CT analysis can help measure subtle structural changes and support follow-up after traumatic brain injury.

Blogs

09/09/2026

Prostate Cancer Awareness Month: Finding the Cancer That Matters

How quantitative MRI can bring greater clarity to decisions across the prostate cancer journey.

Our solutions

Our solutions

About

Support

Resources